Evidence map›Paper›PMID 27959491›Full record

ArticleACS chemical biology2017

Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.

Colleen M Connelly, Robert E Boer, Michelle H Moon, Peter Gareiss, John S Schneekloth

Open access · greenAbstract readValidation Study
In one paragraph

Article in ACS chemical biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Covalent Degrader of the Oncogenic Transcription Factor β-Catenin.Journal of the American Chemical Society · 2024
    Article
  7. Review
  8. Article
  9. Covalent Degrader of the Oncogenic Transcription Factor β-Catenin.bioRxiv : the preprint server for biology · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Targeting RNA structures with small molecules.Nature reviews. Drug discovery · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Colleen M ConnellyChemical Biology Laboratory, National Cancer Institute , Frederick, Maryland 21702, United States.
Robert E BoerChemical Biology Laboratory, National Cancer Institute , Frederick, Maryland 21702, United States.
Michelle H MoonChemical Biology Laboratory, National Cancer Institute , Frederick, Maryland 21702, United States.
Peter GareissYale Center for Molecular Discovery , West Haven, Connecticut 06516, United States.
John S SchneeklothChemical Biology Laboratory, National Cancer Institute , Frederick, Maryland 21702, United States.ORCID 0000-0001-7459-783X
Frederick National Laboratory for Cancer Research · US

Funding

Identification of Nucleic Acid Binding Small MoleculesZIABC011585 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SCHNEEKLOTH, JOHN · 2014 to 2025
$18.6M
Intramural NIH HHS ZIA BC011585
6 · The paper itself

Abstract

The identification of small molecules that bind to and perturb the function of microRNAs is an attractive approach for the treatment for microRNA-associated pathologies. However, there are only a few small molecules known to interact directly with microRNAs. Here, we report the use of a small molecule microarray (SMM) screening approach to identify low molecular weight compounds that directly bind to a pre-miR-21 hairpin. Compounds identified using this approach exhibit good affinity for the RNA (ranging from 0.8-2.0 μM) and are not composed of a polycationic scaffold. Several of the highest affinity compounds inhibit Dicer-mediated processing, while in-line probing experiments indicate that the compounds bind to the apical loop of the hairpin, proximal to the Dicer site. This work provides evidence that small molecules can be developed to bind directly to and inhibit miR-21.

Indexed as

Small Molecule LibrariesHumansMicroRNAsStructure-Activity RelationshipMicroRNAsMIRN21 microRNA, humanSmall Molecule Libraries

Identifiers

PMID27959491
PMCPMC6341489
OpenAlexW2563026380

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.